Most Read Articles
17 May 2020
Increased coffee consumption among regular drinkers is associated with higher estimated glomerular filtration rate and confers protection against the risk of chronic kidney disease stages G3–G5 and albuminuria, as shown in a study.
19 May 2020
A novel telemedicine-based cognitive-behavioural intervention may help manage body image disturbances in survivors of head and neck cancer (HNC), a new study reveals.
4 days ago
Treatment with lenabasum is safe and helps improve outcomes in patients with diffuse cutaneous systemic sclerosis, according to the results of a phase II study.
Audrey Abella, 23 Apr 2020
Among patients undergoing complex percutaneous coronary intervention (PCI) who completed 3 months of dual antiplatelet therapy (DAPT) comprising aspirin and the potent P2Y12-receptor inhibitor ticagrelor, aspirin withdrawal led to fewer bleeding episodes without increasing the risk of ischaemic events compared with continued DAPT, according to data from the TWILIGHT-COMPLEX* subanalysis presented at ACC.20/WCC Virtual.

Product Highlight - Zavicefta

29 Nov 2019

Active ingredient: Ceftazidime (as pentahydrate) equivalent to 2 g and Avibactam (as sodium salt) equivalent to 0.5 g.

Indications: ZAVICEFTATM is indicated in adults for the treatment of the following infections

  • Complicated Intra-Abdominal Infection (cIAI)
  • Complicated Urinary Tract Infection, including Pyelonephritis (cUTI)
  • Hospital-acquired Pneumonia (HAP), including ventilator associated pneumonia (VAP)
  • Infections due to aerobic Gram-negative organisms in patients with limited treatment options
  • Consideration should be given to official guidance on the appropriate use of antibacterial agents. For treatment of cIAI use in combination with metronidazole.

Dosage & Administration: The recommended dosage of ZAVICEFTATM is 1 vial where each vial contains 2 g ceftazidime and 0.5 g avibactam administered by intravenous (IV) infusion in a volume of 100 mL at a constant rate over 120 minutes in patients aged 18 years or older. Treatment is repeated every 8 hours.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
17 May 2020
Increased coffee consumption among regular drinkers is associated with higher estimated glomerular filtration rate and confers protection against the risk of chronic kidney disease stages G3–G5 and albuminuria, as shown in a study.
19 May 2020
A novel telemedicine-based cognitive-behavioural intervention may help manage body image disturbances in survivors of head and neck cancer (HNC), a new study reveals.
4 days ago
Treatment with lenabasum is safe and helps improve outcomes in patients with diffuse cutaneous systemic sclerosis, according to the results of a phase II study.
Audrey Abella, 23 Apr 2020
Among patients undergoing complex percutaneous coronary intervention (PCI) who completed 3 months of dual antiplatelet therapy (DAPT) comprising aspirin and the potent P2Y12-receptor inhibitor ticagrelor, aspirin withdrawal led to fewer bleeding episodes without increasing the risk of ischaemic events compared with continued DAPT, according to data from the TWILIGHT-COMPLEX* subanalysis presented at ACC.20/WCC Virtual.